August 2023 - Clinical Chemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.
Liquid Biopsies: Detecting and Treating Cancer Sooner - Insights
Researchers and physicians at Mayo Clinic are collaborating and developing blood tests that detect tumor related material in the blood and may someday be used in place of a biopsy or imaging test to detect and monitor cancer growth.
The Adoption of Social Media in Education - Insights
Elissa Hall, Associate Director for Curriculum and Education Technology and an Assistant Professor at Mayo Clinic, discusses how the adoption of social media in education creates a flexible environment for facilitating collaborative, deeper...
MML Regional Manager Kate Lynch Bix Retires after 29 Years of Dedicated Service - Insights
Kate Lynch Bix, Mayo Medical Laboratories (MML) Regional Manager, says goodbye after 29 years of dedicated service. When Kate joined MML in 1988, she joined the team of only eight sales staff responsible for covering the entire United...
Present Approaches to Testing - Insights
Discussing current test applications that you can implement in your laboratory or practice today.
February 2023 - Hematopathology Case One - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Hematopathology.
In a recent study, Mayo Clinic researchers developed the first cellular DNA barcoding with a machine-learning approach to reveal previously unknown metastatic behavior of tumor cells. Researchers barcoded the DNA of millions of human...
A Test in Focus Archives - Page 3 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Addiction rehabilitation monitoring - Insights
Encompassing comprehensive profiles, confirmatory testing, and interpretive results reporting, addiction rehabilitation monitoring at Mayo Clinic Laboratories supports patients affected by substance use disorder in their rehabilitation and...
Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.